Evidence map›Paper›PMID 27003444›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2016

Research Resource: Roles for Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) in Systems Metabolism.

Kathrina L Marcelo, Thomas Ribar, Christopher R Means, Anna Tsimelzon, Robert D Stevens, Olga Ilkayeva, James R Bain, Susan G Hilsenbeck, Christopher B Newgard, Anthony R Means and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 35 citations in OpenAlex.

  1. The AMPK Pathway: Molecular Rejuvenation of Metabolism and Mitochondria.Annual review of cell and developmental biology · 2025
    Review
  2. Article
  3. Molecular Mechanisms Underlying CaInternational journal of molecular sciences · 2022
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Whole Exome Sequencing Study in a Family with Type 2 Diabetes Mellitus.International journal of general medicine · 2021
    Article
  13. Complex roles of cAMP-PKA-CREB signaling in cancer.Experimental hematology & oncology · 2020
    Review
  14. Review
  15. Leptin-induced Trafficking of KInternational journal of molecular sciences · 2019
    Review
  16. Friend and foe: β-cell CaMolecular metabolism · 2019
    Review
  17. Review
  18. Inhibition of CaMKK2 Enhances Fracture Healing by Stimulating Indian Hedgehog Signaling and Accelerating Endochondral Ossification.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Kathrina L MarceloDepartment of Molecular and Cellular Biology (K.L.M., A.R.M., B.Y.), Baylor College of Medicine, Houston, Texas 77030; Departments of Cell, Pharmacology and Cancer Biology (T.R.), Duke University School of Medicine, Durham, North Carolina 27710; Mouse Behavior and Neuroendocrine Analysis Core Facility (C.R.M.), Duke University School of Medicine, Durham, North Carolina 27710; Lester and Sue Smith Breast Center (A.T., S.G.H.), Baylor College of Medicine, Houston, Texas 77030; Sarah W. Stedman Nutrition and Metabolism Center (R.D.S., O.I., J.R.B., C.B.N.), Duke University Medical Center, Durham, North Carolina 27710; and Dan L. Duncan Cancer Center (A.R.M., B.Y.), Baylor College of Medicine, Houston, Texas 77030.
Thomas RibarDepartment of Molecular and Cellular Biology (K.L.M., A.R.M., B.Y.), Baylor College of Medicine, Houston, Texas 77030; Departments of Cell, Pharmacology and Cancer Biology (T.R.), Duke University School of Medicine, Durham, North Carolina 27710; Mouse Behavior and Neuroendocrine Analysis Core Facility (C.R.M.), Duke University School of Medicine, Durham, North Carolina 27710; Lester and Sue Smith Breast Center (A.T., S.G.H.), Baylor College of Medicine, Houston, Texas 77030; Sarah W. Stedman Nutrition and Metabolism Center (R.D.S., O.I., J.R.B., C.B.N.), Duke University Medical Center, Durham, North Carolina 27710; and Dan L. Duncan Cancer Center (A.R.M., B.Y.), Baylor College of Medicine, Houston, Texas 77030.
Christopher R MeansDepartment of Molecular and Cellular Biology (K.L.M., A.R.M., B.Y.), Baylor College of Medicine, Houston, Texas 77030; Departments of Cell, Pharmacology and Cancer Biology (T.R.), Duke University School of Medicine, Durham, North Carolina 27710; Mouse Behavior and Neuroendocrine Analysis Core Facility (C.R.M.), Duke University School of Medicine, Durham, North Carolina 27710; Lester and Sue Smith Breast Center (A.T., S.G.H.), Baylor College of Medicine, Houston, Texas 77030; Sarah W. Stedman Nutrition and Metabolism Center (R.D.S., O.I., J.R.B., C.B.N.), Duke University Medical Center, Durham, North Carolina 27710; and Dan L. Duncan Cancer Center (A.R.M., B.Y.), Baylor College of Medicine, Houston, Texas 77030.
Anna TsimelzonDepartment of Molecular and Cellular Biology (K.L.M., A.R.M., B.Y.), Baylor College of Medicine, Houston, Texas 77030; Departments of Cell, Pharmacology and Cancer Biology (T.R.), Duke University School of Medicine, Durham, North Carolina 27710; Mouse Behavior and Neuroendocrine Analysis Core Facility (C.R.M.), Duke University School of Medicine, Durham, North Carolina 27710; Lester and Sue Smith Breast Center (A.T., S.G.H.), Baylor College of Medicine, Houston, Texas 77030; Sarah W. Stedman Nutrition and Metabolism Center (R.D.S., O.I., J.R.B., C.B.N.), Duke University Medical Center, Durham, North Carolina 27710; and Dan L. Duncan Cancer Center (A.R.M., B.Y.), Baylor College of Medicine, Houston, Texas 77030.
Robert D StevensDepartment of Molecular and Cellular Biology (K.L.M., A.R.M., B.Y.), Baylor College of Medicine, Houston, Texas 77030; Departments of Cell, Pharmacology and Cancer Biology (T.R.), Duke University School of Medicine, Durham, North Carolina 27710; Mouse Behavior and Neuroendocrine Analysis Core Facility (C.R.M.), Duke University School of Medicine, Durham, North Carolina 27710; Lester and Sue Smith Breast Center (A.T., S.G.H.), Baylor College of Medicine, Houston, Texas 77030; Sarah W. Stedman Nutrition and Metabolism Center (R.D.S., O.I., J.R.B., C.B.N.), Duke University Medical Center, Durham, North Carolina 27710; and Dan L. Duncan Cancer Center (A.R.M., B.Y.), Baylor College of Medicine, Houston, Texas 77030.
Olga IlkayevaDepartment of Molecular and Cellular Biology (K.L.M., A.R.M., B.Y.), Baylor College of Medicine, Houston, Texas 77030; Departments of Cell, Pharmacology and Cancer Biology (T.R.), Duke University School of Medicine, Durham, North Carolina 27710; Mouse Behavior and Neuroendocrine Analysis Core Facility (C.R.M.), Duke University School of Medicine, Durham, North Carolina 27710; Lester and Sue Smith Breast Center (A.T., S.G.H.), Baylor College of Medicine, Houston, Texas 77030; Sarah W. Stedman Nutrition and Metabolism Center (R.D.S., O.I., J.R.B., C.B.N.), Duke University Medical Center, Durham, North Carolina 27710; and Dan L. Duncan Cancer Center (A.R.M., B.Y.), Baylor College of Medicine, Houston, Texas 77030.
James R BainDepartment of Molecular and Cellular Biology (K.L.M., A.R.M., B.Y.), Baylor College of Medicine, Houston, Texas 77030; Departments of Cell, Pharmacology and Cancer Biology (T.R.), Duke University School of Medicine, Durham, North Carolina 27710; Mouse Behavior and Neuroendocrine Analysis Core Facility (C.R.M.), Duke University School of Medicine, Durham, North Carolina 27710; Lester and Sue Smith Breast Center (A.T., S.G.H.), Baylor College of Medicine, Houston, Texas 77030; Sarah W. Stedman Nutrition and Metabolism Center (R.D.S., O.I., J.R.B., C.B.N.), Duke University Medical Center, Durham, North Carolina 27710; and Dan L. Duncan Cancer Center (A.R.M., B.Y.), Baylor College of Medicine, Houston, Texas 77030.
Susan G HilsenbeckDepartment of Molecular and Cellular Biology (K.L.M., A.R.M., B.Y.), Baylor College of Medicine, Houston, Texas 77030; Departments of Cell, Pharmacology and Cancer Biology (T.R.), Duke University School of Medicine, Durham, North Carolina 27710; Mouse Behavior and Neuroendocrine Analysis Core Facility (C.R.M.), Duke University School of Medicine, Durham, North Carolina 27710; Lester and Sue Smith Breast Center (A.T., S.G.H.), Baylor College of Medicine, Houston, Texas 77030; Sarah W. Stedman Nutrition and Metabolism Center (R.D.S., O.I., J.R.B., C.B.N.), Duke University Medical Center, Durham, North Carolina 27710; and Dan L. Duncan Cancer Center (A.R.M., B.Y.), Baylor College of Medicine, Houston, Texas 77030.
Christopher B NewgardDepartment of Molecular and Cellular Biology (K.L.M., A.R.M., B.Y.), Baylor College of Medicine, Houston, Texas 77030; Departments of Cell, Pharmacology and Cancer Biology (T.R.), Duke University School of Medicine, Durham, North Carolina 27710; Mouse Behavior and Neuroendocrine Analysis Core Facility (C.R.M.), Duke University School of Medicine, Durham, North Carolina 27710; Lester and Sue Smith Breast Center (A.T., S.G.H.), Baylor College of Medicine, Houston, Texas 77030; Sarah W. Stedman Nutrition and Metabolism Center (R.D.S., O.I., J.R.B., C.B.N.), Duke University Medical Center, Durham, North Carolina 27710; and Dan L. Duncan Cancer Center (A.R.M., B.Y.), Baylor College of Medicine, Houston, Texas 77030.
Anthony R MeansDepartment of Molecular and Cellular Biology (K.L.M., A.R.M., B.Y.), Baylor College of Medicine, Houston, Texas 77030; Departments of Cell, Pharmacology and Cancer Biology (T.R.), Duke University School of Medicine, Durham, North Carolina 27710; Mouse Behavior and Neuroendocrine Analysis Core Facility (C.R.M.), Duke University School of Medicine, Durham, North Carolina 27710; Lester and Sue Smith Breast Center (A.T., S.G.H.), Baylor College of Medicine, Houston, Texas 77030; Sarah W. Stedman Nutrition and Metabolism Center (R.D.S., O.I., J.R.B., C.B.N.), Duke University Medical Center, Durham, North Carolina 27710; and Dan L. Duncan Cancer Center (A.R.M., B.Y.), Baylor College of Medicine, Houston, Texas 77030.
Brian YorkDepartment of Molecular and Cellular Biology (K.L.M., A.R.M., B.Y.), Baylor College of Medicine, Houston, Texas 77030; Departments of Cell, Pharmacology and Cancer Biology (T.R.), Duke University School of Medicine, Durham, North Carolina 27710; Mouse Behavior and Neuroendocrine Analysis Core Facility (C.R.M.), Duke University School of Medicine, Durham, North Carolina 27710; Lester and Sue Smith Breast Center (A.T., S.G.H.), Baylor College of Medicine, Houston, Texas 77030; Sarah W. Stedman Nutrition and Metabolism Center (R.D.S., O.I., J.R.B., C.B.N.), Duke University Medical Center, Durham, North Carolina 27710; and Dan L. Duncan Cancer Center (A.R.M., B.Y.), Baylor College of Medicine, Houston, Texas 77030.
Baylor College of Medicine · USDuke University · USDuke Medical Center · USDuke University Hospital · US

Funding

STRUCTURE/FUNCTION OF GENETIC ENGINEERED CALMODULINSR01GM033976 · NIGMS · DUKE UNIVERSITY · PI MEANS, ANTHONY R · 1985 to 2015
$5.4M
NIGMS NIH HHS R01 GM033976
6 · The paper itself

Abstract

A number of epidemiological studies have implicated calcium (Ca(2+)) signaling as a major factor in obesity that contributes to aberrant systems metabolism. Somewhat paradoxically, obesity correlates with decreased circulating Ca(2+) levels, leading to increased release of intracellular Ca(2+) stores from the endoplasmic reticulum. These findings suggest that insulin resistance associated with the obese state is linked to activation of canonical Ca(2+) signaling pathways. Mechanistically, increased intracellular Ca(2+) binds calmodulin (CaM) to activate a set of Ca(2+)/CaM-dependent protein kinases. In this research resource, we explore the metabolic functions and implications of Ca(2+)/CaM-dependent protein kinase kinase 2 (CaMKK2) as a metabolic effector of Ca(2+)/CaM action. We reveal the importance of CaMKK2 for gating insulin release from pancreatic β-cells while concomitantly influencing the sensitivity of insulin-responsive tissues. To provide a better understanding of the metabolic impact of CaMKK2 loss, we performed targeted metabolomic analyses of key metabolic byproducts of glucose, fatty acid, and amino acid metabolism in mice null for CaMKK2. We quantified amino acids and acyl carnitines in 3 insulin-sensitive tissues (liver, skeletal muscle, plasma) isolated from CaMKK2(-/-) mice and their wild-type littermates under conditions of dietary stress (low-fat diet, normal chow, high-fat diet, and fasting), thereby unveiling unique metabolic functions of CaMKK2. Our findings highlight CaMKK2 as a molecular rheostat for insulin action and emphasize the importance of Ca(2+)/CaM/CaMKK2 in regulation of whole-body metabolism. These findings reveal that CaMKK2 may be an attractive therapeutic target for combatting comorbidities associated with perturbed insulin signaling.

Indexed as

Amino AcidsAnimalsCalciumCalcium-Calmodulin-Dependent Protein Kinase KinaseCalmodulinDiet, High-FatEndoplasmic ReticulumFatty AcidsGlucoseInsulinInsulin ResistanceInsulin-Secreting CellsLiverMaleMiceMice, Inbred C57BLAmino AcidsCalciumCalcium-Calmodulin-Dependent Protein Kinase KinaseCalmodulinCamkk2 protein, mouseFatty AcidsGlucoseInsulin

Identifiers

PMID27003444
PMCPMC4853564
OpenAlexW2306435206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.